Improving Prognostic and Fibrotic Evaluation of Chronic Kidney Disease with Contrast‐Enhanced Ultrasound Index Derived Peak Intensity: an observational study

Yao Xu,Hongli Li,Chunlin Wang,Minfang Zhang,Qin Wang,Yuanyuan Xie,Xinghua Shao,Lei Tian,Yanhong Yuan,Wei Yan,Tienan Feng,Fenghua Li,Zhaohui Ni,Shan Mou
DOI: https://doi.org/10.21203/rs.2.13521/v1
2019-01-01
Abstract:Background Chronic kidney disease (CKD) is a progressive disease with high morbidity and mortality. Contrast-enhanced ultrasonography (CEUS) has emerged as a cost-effective novel non-invasive imaging technique to improve the diagnosis and predict CKD progression. Methods Patients diagnosed with CKD who underwent CEUS with intravenous bolus contrast 1.5 ml SonoVue during 2014 to December 2014 at Ren Ji hospital, Shanghai, China, were enrolled in this study. Time-intensity curves and quantitative indexes were created using QLAB quantification software. Kidney biopsies were analyzed with α-SMA immunohistochemistry. The Cox proportional hazards model was used to investigate the risk factors for kidney survival. Results Out of 167 CKD patients followed for a median of 23.6±11.3 months, 29 (17.4%) exhibited CKD progression with decline in glomerular filtration rate of more than 25% or end-stage renal disease. Multivariate Cox regression analysis revealed lower derived peak intensity (DPI) was independently associated with progression of kidney disease. Patients with DPI≤11.98db had more severe renal fibrosis and less likely to recover from CKD progression. Conclusions This study demonstrated that the DPI is a reliable CEUS parameter for the evaluation of renal function and independent predictor for the prognosis of CKD patients.
What problem does this paper attempt to address?